Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.

scientific article

Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12028-016-0271-9
P698PubMed publication ID27076286

P50authorBradley J MolyneauxQ57422778
P2093author name stringDavid O Okonkwo
Ryan M Rivosecchi
Joseph Durkin
P2860cites workEvidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesQ24632951
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationQ28262545
Traumatic head injury in the anticoagulated elderly patient: a lethal combination.Q34454622
Risk of thromboembolism following acute intracerebral hemorrhageQ35018742
A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patientsQ36146339
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.Q38415781
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.Q38446560
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.Q38682353
Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhageQ44440532
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhageQ44865336
Degree of anticoagulation, but not warfarin use itself, predicts adverse outcomes after traumatic brain injury in elderly trauma patientsQ44954721
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhageQ45081496
Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortalityQ46872824
Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxisQ48163528
Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhageQ48412367
Early hemorrhage growth in patients with intracerebral hemorrhageQ48821770
Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.Q48876772
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.Q49155525
Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentratQ53539960
Intracerebral hematomas during anticoagulant treatmentQ68784254
Hematoma growth in oral anticoagulant related intracerebral hemorrhageQ81785203
P433issue3
P921main subject(RS)-warfarinQ407431
prothrombin complex concentrateQ2044524
P304page(s)359-364
P577publication date2016-12-01
P1433published inNeurocritical CareQ15745303
P1476titleSafety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage
P478volume25

Reverse relations

cites work (P2860)
Q53281342Anticoagulation reversal in vitamin K antagonist-associated intracerebral hemorrhage: a systematic review.
Q48626887Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
Q55272081Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors.
Q48282136Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage

Search more.